BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 26888041)

  • 1. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
    Batrakova EV; Kim MS
    J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
    Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
    ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances of using polyhydroxyalkanoate-based nanovehicles as therapeutic delivery carriers.
    Li Z; Loh XJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27595635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in imaging strategies for in vivo tracking of exosomes.
    Betzer O; Barnoy E; Sadan T; Elbaz I; Braverman C; Liu Z; Popovtzer R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1594. PubMed ID: 31840427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-mediated small RNA delivery for gene therapy.
    Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.
    Kelley WJ; Safari H; Lopez-Cazares G; Eniola-Adefeso O
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):909-926. PubMed ID: 27194461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral chemistry: the chemical functionalization of viral architectures to create new technology.
    Chen Z; Li N; Li S; Dharmarwardana M; Schlimme A; Gassensmith JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):512-34. PubMed ID: 26663821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
    Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
    J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges.
    Shahabipour F; Banach M; Sahebkar A
    Arch Med Sci; 2016 Dec; 12(6):1324-1326. PubMed ID: 27904525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies.
    Yang F; Liao X; Tian Y; Li G
    Biotechnol J; 2017 Apr; 12(4):. PubMed ID: 28166394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoactivated drug delivery and bioimaging.
    Yang Y; Mu J; Xing B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.